Response to: ‘Efficacy and safety of duloxetine in osteoarthritis or chronic low back pain? The tip of an iceberg!’

We thank Professor Braillon for his comments1 on our article2. Although our meta-analysis was strictly consistent with the PRISMA statement3, Professor Braillon raised a number of concerns about our work. Here, we will answer each of Professor Braillon ’s questions.

Source: Osteoarthritis and Cartilage - February 26, 2021 Category: Rheumatology Authors: Chenghua Weng, Zhichun Liu Tags: Letter to the Editor Source Type: research